Study of ASLAN001 in Combination With Capecitabine in MBC That Has Failed on Prior Trastuzumab
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: ASLAN001|DRUG: Lapatinib|DRUG: Capecitabine
Sponsor: ASLAN Pharmaceuticals